Abstract
The article is an opinion on the problem of venous thromboembolic (VTE) complications in patients with chronic kidney disease (CKD), which is significant and urgent for Russia. Signs of CKD are noted in more than 1/3 of patients with chronic heart failure; a decrease in kidney function is observed in 36% of people over the age of 60, in people of working age, a decrease in function is noted in 16% of cases, and in the presence of cardiovascular diseases increases to 26%. Clinical research data convincingly show that CKD is an independent risk factor for the development of VTE complications. The last decade has given us the opportunity to observe a kind of "revolution" in VTE therapy, which is associated with the appearance on the market of direct oral anticoagulants, including inhibitors of factor IIa (thrombin) and factor Xa. These drugs are approved by the Food and Drug Administration for the treatment of acute thromboembolism. Nevertheless, patients with severe CKD (estimated glomerular filtration rate 30 ml/min) are still limited to the use of unfractionated heparin and vitamin K antagonists, as there is insufficient data to support the use of direct oral anticoagulants in this population.
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference36 articles.
1. Хроническая болезнь почек. Клинические рекомендации. Ассоциация нефрологов РФ. 2021; с. 12-7 [Khronicheskaia bolezn' pochek. Klinicheskie rekomendatsii. Assotsiatsiia nefrologov RF. 2021; s. 12-7 (in Russian)].
2. Notice
3. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure
4. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2007 гг. (Аналитический отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ. 2009;11(3):144-233 [Bikbov BT, Tomilina NA. The state of substitution therapy in patients with chronic renal insufficiency in the Russian Federation in 1998–2007 (Analytical report according to the Russian Register of Renal Replacement Therapy). Nefrologiia i dializ. 2009;11(3):144-233 (in Russian)].